Immunopathology of primary biliary cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 6, 1999, Pages 587-593

  Joplin, Ruth E ^a   Neuberger, James M ^a  

^a NONE

Author keywords

Anti mitochondrial antibodies; Autoimmunity; B cells; Biliary epithelium; Primary biliary cirrhosis; Pyruvate dehydrogenase dihydrolipoamide acetyltransferase; T cells

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CELL ADHESION MOLECULE; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOCHONDRIAL ENZYME; PYRUVATE DEHYDROGENASE PHOSPHATASE;

ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; BILE DUCT; CELLULAR IMMUNITY; EPITHELIUM CELL; HUMAN; IMMUNOPATHOLOGY; MITOCHONDRION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0032812582     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199906000-00002     Document Type: Review

References (42)

1. 1 Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965; i:827-829. Demonstration of anti-mitochondrial antibody reaction using the serum of patients with PBC and indirect immunofluorescence staining.
2. 2 Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70kD nnitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138:3525-3531. Molecular cloning of the cDNA sequence encoding the major M2 mitochondrial antigen in PBC.
3. 3 Coppel RL, McNeilage J, Surh CD, Van de Water J, Spithill TW, Whittingham S, et al. Primary structure of the human M2 mitochondrial autoantigen of PBC: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci USA 1988; 85:7317-7321.
4. 4 Fussey SPM, Guest JR, James OFW, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in PBC. Proc Natl Acad Sci USA 1988; 85:8654-8658. Papers from two key groups who simultaneously identified the major M2 mitochondrial antigen as the dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex (PDC-E2). Identification of the antigen opened the way for subsequent studies to characterize B-lymphocyte and T-cell epitopes of PDC-E2 and other M2 autoantigens.
5. 5 Leung PSC, Van de Water J, Coppel RL, Gershwin ME. Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol Res 1991; 10:518-543.
6. 6 Courvalin JC, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990; 172:961-967.
7. 7 Szostecki C, Guldner HH, Netter HJ, Will H. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 1990; 145:4338-4347.
8. 8 Lassoued K, Brenard R, Degos F, Courvalin JC, Andre C, Danon F, et al. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990; 99:181-186.
9. 9 Wesierska-Gadek J, Honenauer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996; 110:840-847.
10. 10 Metcalf JV, Mitchison HC, Palmer JM, Jones DEJ, Bassendine MF, James OFW. Natural history of early primary biliary cirrhosis. Lancet 1996; 348:1399-1402. An important report detailing association between AMA positivity in normal subjects and progression to development of abnormalities associated with PBC. The results imply that positive AMA precedes liver abnormality and may be more than a secondary response to tissue damage.
11. 11 Yeaman SJ. The mammalian 2-oxo acid dehydrogenases: a complex family. Trends Biochem Sci 1986; 11:293-296.
12. 12 Surh CD, Coppel RL, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implications for a conformational epitope. J Immunol 1990; 144:3367-3374.
13. 13 Quinn J, Diamond AG, Palmer JM, Bassendine MF, James OFW, Yeaman SJ. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993; 18:1384-1391.
14. 14 Klein R, Pointer H, Zilly W, Glassner Bittner B, Breuer N, Garbe W, et al. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997; 17:119-128.
15. 15 Hoffman RM, Pape GR, Spengler U, Reiber J, Eisenburg J, Dohrmann G, et al. Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis. Clin Exp Immunol 1989; 76:210-215.
16. 16 Miller KB, Elta GH, Rudders RA, Kaplan M. Lymphocyte subsets in primary biliary cirrhosis. Ann Intern Med 1984; 100:385-387.
17. 17 Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T-cells. Hepatology 1996; 24:561-567. Investigation into the antigen-presenting capability of biliary epithelium using cultured BEC. BEC were found to be unable to present antigen to class II restricted T cells in vitro unless antibody to cross-link CD28 was present in the incubating medium. The data suggest that BEC do not themselves carry the molecules required to activate helper/initiator T cells.
18. 18 Van de Water J, Ansari AA, Surh CD, Coppel RL, Roche T, Bonkovsky H, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991; 146:89-94. A study of recognition of recombinant human PDC-E2 by T cells cloned from the liver of patients with PBC: the first demonstration of T-cell recognition of PDC-E2. This paper also describes detection of aberrant distribution of PDC-E2 on biliary epithelium of patients with PBC using a mouse monoclonal antibody.
19. 19 Harada K, Van de Water J, Leung PSC, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25:791-796.
20. 20 Jones DEJ, Palmer JM, Yeaman SJ, James OFW, Bassendine MF, Diamond AG. T cell responses to components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995; 21:995-1002. Demonstration of peripheral blood lymphocyte recognition of natural human PDC-E2: T-cell epitopes were identified throughout the molecule.
21. 21 Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence for molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181:1835-1845. Identification of immunodominant T-cell epitopes of PDC-E2 using cloned peripheral blood T cells from Japanese patients with PBC.
22. 22 Palmer JM, Jones DEJ, Yeaman SJ, Diamond AG, Bassendine MF. T-cell responses to the putative dominant T-cell autoepitope in primary biliary cirrhosis: the role of lipoylation [Abstract]. Hepatology 1997; 26(4):439A.
23. 23 Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984; ii:1009-1011. This study demonstrated de novo expression of MHC class II antigens on biliary epithelium of patients with PBC, with the implication of a key role for aberrant expression of MHC class II in induction of autoimmunity. The role of MHC class II in immune cell recognition and destruction of biliary epithelium has still to be determined.
24. 24 Adams DH, Hubscher S, Shaw J, Johnson GD, Rothlien R, Neuberger JM. Increased expression of intercellular adhesion molecule-1 (ICAM-1) on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14:426-431.
25. 25 Hu WN, Blazar BR, Manivel JC, Manviel JC, Paradis K, Sharp HL. Phenotypical and functional characterization of intrahepatic bile duct cells from common bile duct ligated mice. J Lab Clin Med 1996; 128:536-544.
26. 26 Ayres RCS, Neuberger JM, Shaw J, Joplin R, Adams RH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993; 34:125-129.
27. 27 Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 1997; 112:968-977.
28. 28 Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991; 13:239-246. Demonstration that normal human biliary epithelial cells can be induced to express MHC class II in vitro in response to incubation with pro-inflammatory cytokines.
29. 29 Tsuneyama K, Van de Water J, Leung PSC, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before MHC Class II and BB1/B7 expression. Hepatology 1995; 21:1031-1037. A key paper in determining a possible significance for PDC-E2 in the immunopathology of PBC. Using sequential biopsy specimens it was determined that aberrant distribution of PDC-E2 on biliary epithelium precedes de novo expression of MHC class II or lymphocyte co-stimulatory molecules, implying that aberrant PDC-E2 is one of the earliest detectable abnormalities within the liver and may be intimately related to initiating events in PBC.
30. 30 Kaji K, Tsuneyama K, Nakanuma Y, Harada K, Sasaki M, Kaneko S, et al. B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C. J Gastroenterol Hepatol 1997; 12:507-512.
31. 31 Leon MP, Kirby JA, Gibbs P, Burt A, Bassendine MF. Immunogenicity of biliary epithelial cells - study of expression of B7 molecules. J Hepatol 1995; 22:591-595. In conflict with immunohistochemical studies [29,30], this study suggested that lymphocyte co-stimulatory molecules are not expressed by human BEC in vitro.
32. 32 Joplin R, Wallace LL, Johnson GD, Lindsay JG, Yeaman SJ, Palmer JM, et al. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J Pathol 1995; 176:381-390. In this study, antibodies to PDC-E2 were found to bind to antigen on the external aspect of the plasma membrane of BEC purified from patients with PBC but not controls. The data suggested a mechanism whereby BEC could become targets for immunological recognition.
33. 33 Joplin R, Wallace LL, Lindsay JG, Palmer JM, Yeaman SJ, Neuberger JM. The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? Gastroenterology 1997; 113:1727-1733. The plasma membrane antigen recognized by antibodies to PDC-E2 was characterized. No evidence was found for cross-reactivity at the B-cell level; AMA reacted only with PDC-E2 and PDC-E3bp. Only PDC-E3bp was associated with the plasma membrane.
34. 34 Krams S, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase as a recombinant polypeptide generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989; 9:411-416.
35. 35 Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts K, et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996; 24:1079-1084. Another key paper in determining the possible significance of PDC-E2 in immunopathology. Aberrant PDC-E2 was determined in biopsy specimens of allografts from liver transplant recipients. Parallels are apparent with [29]; aberrant PDC-E2 may be the earliest detectable abnormality in the liver and may precede not only PBC but also recurrent PBC in liver allografts.
36. 36 Joplin R, Lindsay JG, Hubscher SG, Strain AJ, Neuberger JM. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 1991; 14:442-447. This paper records the observation that aberrant distribution of PDC-E2 in patients with PBC is not restricted to BEC but is also found in cells in the draining lymph nodes of the liver.
37. 37 Hubscher SG, Elias E, Buckels JA, Mayer DA, McMaster P, Neuberger JM. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18:173-184.
38. 38 Dmetrewski J, Mayer AD, Hubscher SG, Neuberger JM. Histological recurrence of primary biliary cirrhosis after liver transplantation: effect of immunosuppression. J Hepatol 1996; 24:253-257. This paper supports the earlier suggestion of recurrence of PBC in the allograft and demonstrates that recurrence is enhanced in the presence of specific immunosuppressive regimens, suggesting a possible role for an infectious agent in immunopathological mechanisms.
39. 39 Hopf U, Stemerowicz R, Rodloff A, Galanos C, Moller B, Lobeck H, et al. Relation between Escherichia coli R (rough)-forms in gut, lipid A and primary biliary cirrhosis. Lancet 1989; ii:1421-1422.
40. 40 Vilagut L, Vila J, Pares A, Vinas O, Gines A, Bruguera M, et al. Mycobacterium gordonae DNA in liver tissue of patients with primary biliary cirrhosis [Abstract]. J Hepatol 1994; 21:S87.
41. 41 Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JMT, Brumfitt W, Shertock S. Bacteriuria in primary biliary cirrhosis. Gut 1984; 25:133-137.
42. 42 Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger JM. Expression of pyruvate dehydrogenase complex E2 on normal biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998; 352:1595-1596.